Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study
European Radiology · 2025
DOI: 10.1007/s00330-025-12178-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2025. Verfasst von M Dolciami und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. miriam.dolciami@po…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Magnetic Resonance Imaging, Conization. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess the accuracy of MRI in detecting residual disease after conization in patients with early-stage cervical cancer (CC) and to evaluate the impact of MRI on FIGO staging and surgical management. Materials and methods Between January 2018 and December 2023, a consecutive series of patients with early-stage invasive CC undergoing conization, pre-operative pelvic MRI, and surgery were included in this retrospective study. Two experienced radiologists reviewed the MRI scans for the presence of residual tumor, assessed on T2-weighted, diffusion-weighted, and contrast-enhanced sequences, if available. MRI findings were compared with surgical pathology to evaluate diagnostic performance and clinical impact.
Results
A total of 108 patients were included in the study. MRI detected residual disease with an accuracy of 78.7% (95% CI 71.0–86.4), sensitivity of 66%, specificity of 90.9%, positive predictive value of 87.5%, and negative predictive value of 73.5%. The use of contrast agent showed no significant difference in overall accuracy, with an accuracy of 74.5% for contrast-enhanced MRI (CE-MRI) and 83% for non-CE-MRI ( p = 0.28), respectively. MRI correctly staged 73.8% of cases, suggested the correct extent of radicality in 79.7% of cases following the 2018 ESGO guidelines, and the appropriate type of hysterectomy (simple vs. radical) in 90.9% of cases following the SHAPE study.
Conclusion
Non-CE MRI is a reliable and sufficient tool for detecting residual tumor after conization in early-stage CC, as contrast administration offers no additional diagnostic value. Accurate pre-operative identification of residual disease may refine FIGO staging and assist in tailoring surgical strategies. Key Points Question MRI evaluation of residual tumor after cervical conization in early-stage cervical cancer is critical to optimize surgical planning noninvasively and avoid overtreatment.
Findings
MRI correctly identified residual disease with high specificity (90.9%) and moderate sensitivity (66%); contrast enhancement did not significantly improve diagnostic accuracy. Clinical relevance MRI, particularly non-contrast protocols, reliably excludes post-conization residual disease and aids in selecting appropriate surgical treatment, reducing overtreatment in early-stage cervical cancer. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. miriam.dolciami@policlinicogemelli.it.
- Catholic University of the Sacred Heart, Rome, Italy.
- Gynecologic and Obstetric Clinic, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
- Department of Women and Child Health and Public Health, UOC Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Pathology Institute, Catholic University of the Sacred Heart, Rome, Italy.
Zitieren
APA
Dolciami, M., Criscione, M., Bizzarri, N., Amerighi, A., Napoletano, A., Russo, L., Scaglione, G., Giannarelli, D., Petrillo, M., Sala, E., Fanfani, F., & Gui, B. (2025). Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study. European Radiology. https://doi.org/10.1007/s00330-025-12178-9
Vancouver
Dolciami M, Criscione M, Bizzarri N, Amerighi A, Napoletano A, Russo L, et al. Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study. European Radiology. 2025. doi:10.1007/s00330-025-12178-9
BibTeX
@article{Dolciami2025,
author = {Dolciami, M and Criscione, M and Bizzarri, N and Amerighi, A and Napoletano, A and Russo, L and Scaglione, G and Giannarelli, D and Petrillo, M and Sala, E and Fanfani, F and Gui, B},
title = {Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study},
journal = {European Radiology},
year = {2025},
doi = {10.1007/s00330-025-12178-9}
}
EUVIMED